Saturday 17 October 2026
Export IMCC’s income statement to Excel — free account
IM Cannabis Corp.
IMCC Healthcare Drug Manufacturers Specialty & Generic
IM Cannabis Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.2 million, down 0.66% from fiscal 2024. In the quarter to June 2026, revenue fell 40.3%, EPS fell 385.7%, free cash flow fell 266.8% and total debt fell 64.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
1.36
0.03
+2.26%
Follow IMCC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
6 | 5 | 4 | 3 |
| (107.89%) | 5,562.03% | 1,305.05% | 2,280.06% | ||
| (10.32%) | (31.58%) | (40.98%) | (54.20%) | ||
ROIC |
(86.01%) | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
155.22% | 149.84% | 152.29% | 189.48% | |
Average Days of Receivables |
79.58 | 72.35 | 51.83 | 54.63 | |
Free Cash Flow per Share |
(16.85) | 24.18 | 0.60 | (1.58) | |
Free Cash Flow |
(2.73) | 3.41 | 0.12 | (0.49) | |
Capital Expenditures |
(0.01) | 0.04 | (0.01) | (0.01) | |
| Other line items | |||||
Cash ROIC |
(45.34%) | 381.04% | (6.41%) | 20.88% | |
Accounts Receivable Turnover |
3.45 | 4.39 | 4.37 | 4.73 | |
Accounts Payable Turnover |
3.31 | 3.84 | 3.64 | 3.88 | |
Inventory Turnover |
5.50 | 11.94 | 11.91 | 12.29 | |
Average Days of Payables |
66.00 | 97.68 | 69.90 | 77.24 | |
Days of Inventory on Hand |
92.56 | 34.58 | 17.05 | 26.05 | |
Tax Rate |
0.01 | 0.01 | 0.01 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
26.36% | 27.20% | 28.86% | 31.69% | |
Share Based Compensation of Revenue |
1.51% | 0.03% | 0.00% | 0.00% | |
Interest Coverage |
(1.04) | (3.31) | (3.10) | (2.76) | |
Operating CF/Net income |
0.81 | (0.42) | (0.01) | 0.04 | |
Depreciation/Fixed assets |
0.44 | 0.44 | 0.45 | 0.47 | |
Capex/Depreciation |
(0.01) | 0.03 | (0.01) | (0.01) | |
Revenue per Share |
231.32 | 277.41 | 186.38 | 107.24 | |
Operating CF per Share |
(16.78) | 23.90 | 0.67 | (1.54) | |
Capex per Share |
(0.07) | 0.28 | (0.07) | (0.03) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates